Venu Holding Corporation (VENU) has announced a public offering of 18.75M shares of common stock or pre-funded warrants, along with a warrant for each share sold. The price for each share or ...

Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today announced that it intends to ...

Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) ("Calidi” or the "Company”), a biotechnology company pioneering the development of targeted genetic medicines, today announced the pricing of its ...

SAN DIEGO, CA / ACCESS Newswire / March 3, 2026 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump ...

Venu Holding Corporation VENU stock fell on Monday after the company announced the pricing of a $75 million underwritten public offering. Public Offering Details On Sunday, the company announced a ...

Last Tuesday at a suburban Target outside Denver, a two-year-old named Margot went rigid in the cart, arched her back, and ...

Bunker Hill Mining Corp. (“Bunker Hill” or the “Company”) (TSX-V: BNKR | OTCQB: BHLL), is pleased to announce that it has closed its previously announced “best efforts” private placement offering of ...

There is an amended and restated offering document (the “ Amended Offering Document ”) related to the Offering that can be accessed under the Company’s profile at www.sedarplus.ca and on the Company’s ...

Bakkt Holdings, Inc. Class A ( (BKKT)) has issued an update. On February 27, 2026, Bakkt, Inc. entered into a securities purchase agreement with a single institutional investor for a registered direct ...

Kensington Capital Acquisition Corp. VI (the "Company") today announced that it has closed its initial public offering ...

Battalion Oil Corporation's shares have soared due to traders piling in on recent news (Iran) combined with a small float.

Relmada Therapeutics, Inc. (Nasdaq: RLMD, 'Relmada” or the 'Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system indications, today ...